Cargando…

Weight changes following antidiabetic mediation use: Real‐world evidence from health system data

OBJECTIVE: Newer antidiabetic medications such as sodium‐glucose co‐transporter 2 inhibitors (SGLT2i) and glucagon‐like peptide 1 receptor agonists (GLP1RA) result in weight loss in clinical trials. However, the real‐world effectiveness remains unclear. The magnitude of weight change associated with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lyu, Beini, Grams, Morgan E., Inker, Lesley A., Chang, Alex R., Selvin, Elizabeth, Shin, Jung‐Im
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535667/ https://www.ncbi.nlm.nih.gov/pubmed/36238229 http://dx.doi.org/10.1002/osp4.600

Ejemplares similares

Socioeconomic status and use of obesogenic and anti-obesity medications in the United States: A population-based study
por: Lyu, Beini, et al.
Publicado: (2022)

Cystatin C– and Creatinine-Based Estimated Glomerular Filtration Rate, Vascular Disease, and Mortality in Persons With Diabetes in the U.S.
por: Tsai, Ching-Wei, et al.
Publicado: (2014)

Concomitant Use of Diltiazem With Direct Oral Anticoagulants and Bleeding Risk in Atrial Fibrillation
por: Xu, Yunwen, et al.
Publicado: (2022)

Performance of Glomerular Filtration Rate Estimating Equations Before and After Bariatric Surgery
por: Chang, Alex R., et al.
Publicado: (2020)

β2-Microglobulin and β-Trace Protein in Patients Undergoing Bariatric Surgery: Non-GFR Determinants and Panel-estimated GFR Performance
por: Chang, Alex R., et al.
Publicado: (2021)

Use of nephrotoxic medications in adults with chronic kidney disease in Swedish and US routine care
por: Bosi, Alessandro, et al.
Publicado: (2021)

Comparing the association of GFR estimated by the CKD-EPI and MDRD study equations and mortality: the third national health and nutrition examination survey (NHANES III)
por: Shafi, Tariq, et al.
Publicado: (2012)

Long-term trends in the prescription of antidiabetic drugs: real-world evidence from the Diabetes Registry Tyrol 2012–2018
por: Engler, Clemens, et al.
Publicado: (2020)

Using real world data to assess cardiovascular outcomes of two antidiabetic treatment classes
por: Stapff, Manfred Paul
Publicado: (2018)

Proteinuria and Risk of Lower-Extremity Amputation in Patients With Peripheral Artery Disease
por: Shin, Jung-Im, et al.
Publicado: (2019)

Cost-Effectiveness of Oral Antidiabetic Drugs: A Prospective Multicenter Study of Real-World Patients
por: Liu, Gordon, et al.
Publicado: (2021)

Increases in Biomarkers of Hyperglycemia With Age in the Atherosclerosis Risk in Communities (ARIC) Study
por: Warren, Bethany, et al.
Publicado: (2017)

Treating Early-Stage CKD With New Medication Therapies: Results of a CKD Patient Survey Informing the 2020 NKF-FDA Scientific Workshop on Clinical Trial Considerations for Developing Treatments for Early Stages of Common, Chronic Kidney Diseases
por: Damron, Kelli Collins, et al.
Publicado: (2022)

Real-World Evidence for Equality
por: Johnson, C. Erwin, et al.
Publicado: (2021)

Hyperkalemia After Initiating Renin–Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project
por: Bandak, Ghassan, et al.
Publicado: (2017)

Editorial: Real-world data and real-world evidence in hematologic malignancies
por: Malagola, Michele, et al.
Publicado: (2023)

Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real‐world data analysis
por: Colosimo, Santo, et al.
Publicado: (2021)

Optimizing weight control in diabetes: antidiabetic drug selection
por: Kalra, S, et al.
Publicado: (2010)

Retinopathy and Risk of Kidney Disease in Persons With Diabetes
por: Hong, Jingyao, et al.
Publicado: (2021)

Informing real-world practice with real-world evidence: the value of PRECIS-2
por: Neta, Gila, et al.
Publicado: (2018)

Proceed with Caution When Using Real World Data and Real World Evidence
por: Kim, Hun-Sung, et al.
Publicado: (2019)

4505 Implementation of Real-World Data and Real-World Evidence in Clinical Studies
por: Pham, Jessica, et al.
Publicado: (2020)

The Missing Reality of Real Life in Real‐World Evidence
por: Okun, Sally
Publicado: (2019)

Heart failure hospitalization risk associated with use of two classes of oral antidiabetic medications: an observational, real-world analysis
por: Gautam, Santosh, et al.
Publicado: (2017)

Real World Use of Antidiabetic Drugs in the Years 2011–2017: A Population-Based Study from Southern Italy
por: Ingrasciotta, Ylenia, et al.
Publicado: (2020)

Real world evidence: An Indian perspective
por: Dang, Amit, et al.
Publicado: (2016)

The quality of research with real-world evidence
por: Palacios, Mauricio
Publicado: (2019)

Introduction to real-world evidence studies
por: Chodankar, Deepa
Publicado: (2021)

Automating Access to Real-World Evidence
por: Gauthier, Marie-Pier, et al.
Publicado: (2022)

Real-World Evidence: A Primer
por: Dang, Amit
Publicado: (2023)

The Disruptive Force of Real-World Evidence
por: Schmitt-Egenolf, Marcus
Publicado: (2023)

Diabetes and Trajectories of Estimated Glomerular Filtration Rate: A Prospective Cohort Analysis of the Atherosclerosis Risk in Communities Study
por: Warren, Bethany, et al.
Publicado: (2018)

Antidiabetic Effects of Hydroxytyrosol: In Vitro and In Vivo Evidence
por: Vlavcheski, Filip, et al.
Publicado: (2019)

Prophylaxis of cancer-associated venous thromboembolism with low-molecular-weight heparin-tinzaparin: Real world evidence
por: Christopoulou, Athina, et al.
Publicado: (2022)

Comparative Prognostic Performance of Definitions of Prediabetes in the Atherosclerosis Risk in Communities (ARIC) Study
por: Warren, Bethany, et al.
Publicado: (2016)

APOL1 Risk Alleles, Cardiac Markers, and Risk of ESKD in African Americans: The Atherosclerosis Risk in Communities Study
por: Surapaneni, Aditya L., et al.
Publicado: (2020)

Real-World Effectiveness and Safety of Lixisenatide as Add-On to Oral Antidiabetic Drugs as Part of Routine Clinical Practice in Bulgaria: LIXODAR Study
por: Temelkova, Nataliya, et al.
Publicado: (2019)

Antidiabetic therapy in real practice: indicators for adherence and treatment cost
por: Colombo, Giorgio L, et al.
Publicado: (2012)

Protection of diabetes in aortic abdominal aneurysm: Are antidiabetics the real effectors?
por: Picatoste, Belén, et al.
Publicado: (2023)

Current Status, Challenges, and Future Perspectives of Real-World Data and Real-World Evidence in Japan
por: Hiramatsu, Katsutoshi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l32erv40hnj0nue2u94pim0kr7